Predictive Oncology (FRA:S1K) Total Assets : €9.75 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology Total Assets?

Predictive Oncology's Total Assets for the quarter that ended in Mar. 2024 was €9.75 Mil.

During the past 12 months, Predictive Oncology's average Total Assets Growth Rate was -16.40% per year. During the past 3 years, the average Total Assets Growth Rate was -22.80% per year. During the past 5 years, the average Total Assets Growth Rate was -7.70% per year. During the past 10 years, the average Total Assets Growth Rate was 37.00% per year.

During the past 13 years, Predictive Oncology's highest 3-Year average Total Assets Growth Rate was 208.10%. The lowest was -45.20%. And the median was 39.90%.

Total Assets is connected with ROA %. Predictive Oncology's annualized ROA % for the quarter that ended in Mar. 2024 was -135.15%. Total Assets is also linked to Revenue through Asset Turnover. Predictive Oncology's Asset Turnover for the quarter that ended in Mar. 2024 was 0.03.

Predictive Oncology Total Assets Historical Data

The historical data trend for Predictive Oncology's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology Total Assets Chart

Predictive Oncology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

20.14

10.74

38.74

24.29

13.22

Predictive Oncology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															23.41	19.35	17.02	13.22	9.75

Predictive Oncology Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Predictive Oncology's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	7.585	+	5.635
	=	13.22

Predictive Oncology's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	3.73	+	6.024
	=	9.75

Predictive Oncology (FRA:S1K) Total Assets Explanation

Total Assets is connected with ROA %.

Predictive Oncology's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-15.524	/	( (13.22	+	9.753)	/ 2 )
	=	-15.524	/	11.4865
	=	-135.15 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Predictive Oncology's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.386	/	( (13.22	+	9.753)	/ 2 )
=	0.386	/	11.4865
=	0.03

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Predictive Oncology Total Assets Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Predictive Oncology (FRA:S1K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

POAI:USA

Address

2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121

Website

https://www.predictive-oncology.com

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Predictive Oncology (FRA:S1K) Headlines

No Headlines